menu ☰
menu ˟

Recombinant growth hormone for children and adolescents with Turner syndrome

Creator:

Baxter, L., Bryant, J., Cave, C.B. and Milne, R.

Subject Keywords: Genetic endocrine disorder
Topic: Chronic Conditions
Conditions
Diabetes
Chronic Conditions
Type: Article
Region: International (other)
Description:

Turner syndrome (TS) affects about one in 1500 to 2500 live-born females. One of the most prevalent and salient features of the syndrome is extremely short stature. Untreated women are approximately 20 to 21 cm shorter than normal women within their respective populations. Recombinant human growth hormone (hGH) has been used to increase growth and final height in girls who have Turner syndrome.
The objective of this review is to assess the effects of recombinant growth hormone in children and adolescents with TS.

Date:

21/01/2008

Rights: © The Cochrane Collaboration
Suggested citation:

Baxter, L., Bryant, J., Cave, C.B. and Milne, R.. (2008) Recombinant growth hormone for children and adolescents with Turner syndrome [Online]. Available from: http://publichealthwell.ie/node/96726 [Accessed: 17th June 2019].

  

View your saved citations and reading lists

Contributor:

Other partner websites
 
Click here to view all the resources gathered from this organisation's website.